Renin angiotensin system blockers before cardiovascular surgery

12/4/2013 | American Journal of Kidney Diseases

Preoperative use of angiotensin converting enzyme inhibitors or angiotensin receptor blockers is controversial. There are conflicting reports of their contribution to the incidence of postoperative acute kidney injury and mortality. This meta-anlysis by Yacoub et al. found that using RAS blockers before cardiovascular surgery is associated with a statistically significant 17% increased odds of postoperative kidney failure and 20% increased odds of death, potentially reflecting the inability of the kidney to respond to perioperative hemodynamic challenges.

View Full Article in:

American Journal of Kidney Diseases

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Director, Site Quality Management
CareFusion
Minneapolis, MN
Clinical Project Manager
Abiomed, Inc.
Danvers, MA
Sr. Manager, Regulatory Affairs - International
Integra LifeSciences
Plainsboro, NJ
Associate - Food and Drug
Keller and Heckman LLP
Washington, DC
In house Compliance Officer
Confidential
Pompano Beach, FL